A phase I dose-escalating study of induction gemcitabine/pemetrexed followed by pemetrexed and concurrent upper abdominal radiation therapy in patients with locally advanced pancreatic cancer.
Phase of Trial: Phase I
Latest Information Update: 05 Dec 2018
At a glance
- Drugs Pemetrexed (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions
- 17 Jun 2008 The expected planned completion date changed from 1 Oct 2009 to actual completion date 1 May 2008.
- 17 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2008 Status changed from completed to discontinued as reported by ClinicalTrials.gov.